Fresenius medical care reports strong operating income margin growth in the third quarter of 2024

Organic revenue growth of +2% supported by care enablement and care delivery underlying u.s. dialysis treatment volume growth turns positive exceeding full year fme25 savings target, with additional eur 64 million contribution in q3 both segments further increased operating income1 and operating income margin1 net financial leverage ratio further improved to 2.8x fy 2024 operating income1 growth outlook with 16-18% tightened toward the upper end of the previous range bad homburg, germany , nov. 5, 2024 /prnewswire/ -- "in the third quarter, we continued the improvement of our financial performance, recording a meaningful progress in the operating income margin towards our 2025 margin targets. the care delivery margin extended well into the 2025 margin target band while care enablement maintained the significant margin progress realized in the first half year.
FMS Ratings Summary
FMS Quant Ranking